Status:
COMPLETED
Biomechanical and Neurophysiological Evaluation of the Effect of a Motor Block and an Injection of Botulinum Toxin on the Stiffness of the Paretic Sural Triceps Muscle
Lead Sponsor:
Nantes University Hospital
Conditions:
Cerebrovascular Accident
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The research "Biomechanical and neurophysiological evaluation of the effects of a motor block and an injection of botulinum toxin on the stiffness of the paretic sural triceps muscle" will study the r...
Detailed Description
Following a stroke, patients see their motor function impaired, in particular by the establishment of muscular retractions. These affect motor performance of the patients, as for example by impairing ...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Patient with signed consent,
- Be over 18 and under 80 years of age,
- Have suffered a stroke (medical diagnosis),
- Spasticity of the triceps surae with a modified Ashworth score of the triceps sural of at least 1,
- Medical indication to perform a treatment of spasticity of the sural triceps by ITB, requiring a prior selective nerve block to qualify or disqualify this procedure (depending on the effectiveness, reaction / sensations / perceptions of the patient),
- Cognitive abilities compatible with experimentation: absence of language or judgment impairments that prevent the understanding of the research or the expression of agreement. An aphasia severity score \> or equal to 3 will be required for inclusion,
- Be eligible for social security.
- Exclusion Criteria:
- Person in an emergency situation, deprived of liberty, or not benefiting from the social protection system,
- Person under 18 years of age or under any legal protection measure whatsoever,
- Unbalanced epileptic disorder; tension variability,
- History of calf surgery (scarring areas that disrupt ultrasound elastography exploration),
- Disorders related to bed rest: thromboembolic disorders, bedsores, respiratory or digestive disorders,
- Previous botulinum toxin injection injection less than 3 months ago (contraindication to a new botulinum toxin injection),
- Contraindication to an injection of botulinum toxin abobotulinum toxin A (Dysport®),
- Patient under anti-coagulant,
- Aphasia or cognitive impairment interfering with task comprehension,
- Contraindication to ankle manipulation: fracture, phlebitis, pressure sore in the areas of support of the orthosis,
- Pregnant or breastfeeding women.
- Translated with www.DeepL.com/Translator (free version)
Exclusion
Key Trial Info
Start Date :
February 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04717141
Start Date
February 3 2021
End Date
July 10 2023
Last Update
July 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nantes
Nantes, France